top of page
Recent Posts
Great news for the Pulmonary Hypertension (PH) community! Through the Canadian Drug Agency's (CDA) funding initiative for rare diseases,...
As most PH clinics are in large cities, PH patients living in rural or remote areas and who must travel long distances to their clinic...
We are pleased to announce that sotatercept, a new drug for patients diagnosed with pulmonary arterial hypertension (PAH), is now listed...
bottom of page
Comments